Norway· NO-ID_B2FF1A1A-1202-47AF-843B-DD99287AE24A
Remifentanil hameln
A remifentanil product containing remifentanil hydrochloride, registered in Norway by hameln pharma GmbH. The same ATC class is registered in 18 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Remifentanil is registered in 18 of 19 countries.
Countries holding a registration under ATC N01AH06 (remifentanil), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 10 of them publish a price we can compare per daily dose
Remifentanil · ATC N01AH06
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of remifentanil costs, country by country.
Normalised to the WHO defined daily dose (52.5 mcg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Remifentanil · price per daily dose (52.5 mcg)
USD · FX 28 Sept 2026
- FI Finland$0.30
The record
At a glance
FEST (Norway)- Active substance
- Remifentanil Hydrochloride
- Manufacturer
- hameln pharma GmbH
- Country
- Norway (NO)
- ATC code
- N01AH06
- ATC class
- Remifentanil
- Defined daily dose
- 52.5 mcg, P
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_B2FF1A1A-1202-47AF-843B-DD99287AE24A
- no_varenummer0363615 x 2NOK 543.6
- gtin4260016656776
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
123 interactions on record for remifentanil.
Graded by severity as the source publishes them — 18 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Remifentanil · interactions on record
123 records
- 18 severe
- 91 moderate
- 14 info
Most severe, free to view
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- DolasetronA04AA04severe
- PalonosetronA04AA05severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Remifentanil in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandRemifentanil ActavisActavis Group PTC ehf
- SpainREMIFENTANILO ACCORD 2 mg POLVO PARA CONCENTRADO PARA SOLUCION INYECTABLE O PERFUSION EFGAccord Healthcare S.L.U.
- BelgiumRemifentanil Actavis 2 mgActavis Group PTC
- SwedenRemifentanil B. Braun 2 mg Pulver till koncentrat till injektions-/infusionsvätska, lösningB. Braun Melsungen AG
- IrelandRemifentanil 2 mg powder for concentrate for solution for injection or infusionFresenius Kabi Deutschland GmbH
- SwitzerlandRemifentanil Fresenius 2 mg, Pulver für ein Konzentrat zur Herstellung einer InfusionslösungFresenius Kabi (Schweiz) AG
- CzechiaREMIFENTANIL B. BRAUNB. Braun Melsungen AG, Melsungen
- IcelandRemifentanil hamelnhameln pharma gmbh
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Remifentanil Hameln, Remifentanil Kabi
- Belgium · Ultiva
- Bulgaria · Ремифентанил Хамелн, Ремифентанил-Чайкафарма
- Cyprus · Refenta
- Czechia · Remifentanil B. Braun
- Germany · Remifentanil B. Braun, Remifentanil Genmed
- Denmark · Remifentanil B. Braun, Remifentanil Fresenius Kabi
- Estonia · Remifentanil Kabi
- Spain · Remifentanilo Kern Pharma, Remifentanilo Noridem
- Finland · Remifentanil, Remifentanil B. Braun
- France · Remifentanil Piramal, Remifentanil Viatris
- United Kingdom (Northern Ireland) · Remifentanil, Remifentanil B. Braun
- Greece · Dormiden, Remifentanil Anfarm
- Croatia · Remifentanil Hameln
- Ireland · Remifentanil, Remifentanil Fresenius Kabi Deutschland
- Iceland · Remifentanil Hameln
- Italy · Remifentanil Hameln, Remifentanil Mylan Generics
- Lithuania · Remifentanil Kabi
- Luxembourg · Ultiva
- Latvia · Remifentanil Kabi
- Malta · Remifentanil Anfarm, Remifentanil Noridem
- Netherlands · Remifentanil B. Braun, Remifentanil Fresenius Kabi
- Poland · Ultiva
- Portugal · Remifentanilo Accord, Remifentanilo Asklepius
- Romania · Remifentanil Kabi
- Sweden · Remifentanil B. Braun, Remifentanil Hameln
- Slovenia · Remifentanil Hameln
- Slovakia · Remifentanil B. Braun, Ultiva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/86796a99-8d5b-4e02-a7f1-604025b5b60f GET /v1/drugs/86796a99-8d5b-4e02-a7f1-604025b5b60f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Pulver til konsentrat til injeksjons-/infusjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Remifentanil",
"merkevare_id": "ID_B2FF1A1A-1202-47AF-843B-DD99287AE24A",
"name_form_strength": "Remifentanil hameln pulver til konsentrat til injeksjons-/infusjonsvæske, oppløsning 2 mg",
"prescription_group": "A"
}See everything about remifentanil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.